EUVIMEDEUVIMED entdecken
Crossref

The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies—experience from a tertiary care center in Germany

Mikko Reese, Ann-Kathrin Eichelmann, Tobias M Nowacki, Andreas Pascher, Judith C Sporn

Langenbeck's Archives of Surgery · 2024

DOI: 10.1007/s00423-024-03309-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langenbeck's Archives of Surgery, 2024. Verfasst von Mikko Reese und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplant Surgery, University Hospital Münster, Waldeyerstraße 1, 48149, Münster, Germany. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Percutaneous Coronary Intervention, Hyperthermia, Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Peritoneal surface malignancies (PSM) are commonly known to have a dismal prognosis. Over the past decades, novel techniques such as cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and pressurized intraperitoneal aerosol chemotherapy (PIPAC) have been introduced for the treatment of PSM which could improve the overall survival and quality of life of patients with PSM. The decision to proceed with CRS and HIPEC is often challenging due the complexity of the disease, the extent of the procedure, associated side effects, and potential risks. Here, we present our experience with CRS and HIPEC to add to the ongoing discussion about eligibility criteria, technical approach, and expected outcomes and contribute to the evolution of this powerful and promising tool in the multidisciplinary treatment of patients with primary and secondary PSM. METHODS: A single-center retrospective chart review was conducted and included a total of 40 patients treated with CRS and HIPEC from April 2020 to September 2022 at the University Hospital Münster Department of Surgery. All patients had histologically confirmed primary or secondary peritoneal malignancies of various primary origins. RESULTS: Our study included 22 patients with peritoneal metastases from gastric cancer (55%), 8 with pseudomyxoma peritonei (20%), 4 with mesothelioma of the peritoneum (10%), and 6 patients with PSM originating from other primary tumor locations. Median PCI at time of cytoreduction was 4 (0-25). Completeness of cytoreduction score was 0 in 37 patients (92.5%), 1 in two patients (5%), and 2 in one patient (2.5%). Median overall survival across all patients was 3.69 years. CONCLUSION: Complete cytoreduction during CRS and HIPEC can be achieved for patients with low PCI, for patients with high PCI in low-grade malignancies, and even for patients with initially high PCI in high-grade malignancies following a significant reduction of cancer burden due to extensive preoperative treatment with PIPAC and systemic chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsPercutaneous Coronary InterventionHyperthermia, InducedHumansPeritoneumHyperthermic Intraperitoneal ChemotherapyCytoreduction Surgical ProceduresRetrospective StudiesTertiary Care CentersQuality of LifeCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsSurvival Rate

Stichwörter der Autor:innen

CRSCytoreductive surgeryHIPECHyperthermic intraperitoneal chemotherapyPeritoneal cancerPeritoneal metastases

Autor:innen und Institutionen

  • Department of General, Visceral and Transplant Surgery, University Hospital Münster, Waldeyerstraße 1, 48149, Münster, Germany.
  • Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Münster, Albert-Schweitzer-Campus 1, Münster, 48149, Germany.
  • Department of Gastroenterology, UKM Marienhospital Steinfurt, Mauritiusstr. 5, Steinfurt, 48565, Germany.
  • Department of General, Visceral and Transplant Surgery, University Hospital Münster, Waldeyerstraße 1, 48149, Münster, Germany. sporn@uni-muenster.de.

Zitieren

APA

Reese, M., Eichelmann, A. K., Nowacki, T. M., Pascher, A., & Sporn, J. C. (2024). The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies—experience from a tertiary care center in Germany. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-024-03309-9

Vancouver

Reese M, Eichelmann AK, Nowacki TM, Pascher A, Sporn JC. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies—experience from a tertiary care center in Germany. Langenbeck's Archives of Surgery. 2024. doi:10.1007/s00423-024-03309-9

BibTeX
@article{Reese2024,
  author = {Reese, Mikko and Eichelmann, Ann-Kathrin and Nowacki, Tobias M and Pascher, Andreas and Sporn, Judith C},
  title = {The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies—experience from a tertiary care center in Germany},
  journal = {Langenbeck's Archives of Surgery},
  year = {2024},
  doi = {10.1007/s00423-024-03309-9}
}
Kostenlos starten →